🇦🇺 OGIVRI in Australia

OGIVRI (TRASTUZUMAB-DKST) regulatory status in Australia.

Marketing authorisation

TGA

  • Status: likely_approved

OGIVRI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Australia

Frequently asked questions

Is OGIVRI approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for OGIVRI in Australia?

MYLAN GMBH is the originator. The local marketing authorisation holder may differ — check the official source linked above.